Menu

Search

Vasso Apostolopoulos

Vasso Apostolopoulos

Pro Vice-Chancellor, Research Partnerships, Victoria University
PhD 1995, University of Melbourne, and Austin Research Institute

Over 25 years experience in research in the area of vaccines and drugs for cancer and chronic diseases with translational focus. In addition, extensive clinical research background, translating research to clinical trials to commercialisation, and expertise with consulting for pharmaceutical companies. Excellent skills on the commercialisation side of drug development and clinical research. Multidisciplinary research, in the areas of, immunology, crystallography, medicinal chemistry, biochemistry, crystallography, clinical research and drug development.

Cancer, MS and Chronic diseases (such as, diabetes). Translational research, clinical research, vaccine development. Developing new improved vaccines and delivery systems to treat diseases with immunology focus. Strong interest in crystallography and how to use crystallography to design new improved vaccines and drugs.

Areas of research include: cancer, type-1 diabetes, type-2 diabetes, multiple sclerosis, mental health, drug addiction, infectious diseases including the recent SARS-CoV-2 virus which causes COVID-19.

Professional Activities
Grant review panel, NHMRC Australia, Susan Komen Breast Cancer Foundation USA
Grant and Fellowship Assessor, NHMRC, ARC Australia and numerous International granting bodies

Regional Editor, Recent Patents Anti-Cancer Drug Discovery
Section Editor, Current Medicinal Chemistry
Section Editor, Medicinal Chemistry
Editor in Chief, Vaccines (section: toxicology and clinical trials)
Associate Editor, Immunotherapy
Associate Editor, Frontiers in Immunology
Review Editor, Frontiers in Immunotherapies and Vaccines [IF=6.429, Q1] (October 2011 - Present)

Editorial Advisory Board of,
Cancers; Maturitas; Frontiers in Microbial Immunology; Expert Review of Vaccines; Medicinal Chemistry; Acta Biochimica et Biophysica Sinica; Frontiers in Immunotherapies and Vaccines; Biomed Research International (Immunology subject area); Updates in Gynecology and Obstetrics

Guest Editor of,
Expert Review of Vaccines; Journal of Drug Delivery; Molecular Pharmaceutics; Current Pharmaceutical Design; Vaccines; Medicinal Chemistry; Cancers; Vaccines; Brain Sciences

Judging Panel for numerous national and international awards
The Science Advisory Board, USA
NHMRC Research Translation Faculty

Author of over 370 research publications and books, and an inventor of 18 patents and 90 sub-patents

Tuberculosis isn't just a historical disease. Here's how it spreads and who is at risk

Oct 17, 2023 06:47 am UTC| Health

Tuberculosis is often seen as a threat of the past. But it remains a significant concern worldwide, with international travel spreading the disease. While tuberculous is rare in Australia, and we no longer routinely...

I need a flu shot and a COVID booster. Can I get them at the same time?

Jun 03, 2023 03:25 am UTC| Health

Cases of influenza (the flu) and COVID are set to rise over winter, with many Australians looking to protect themselves from both of these respiratory viruses. For most adults, if it has been six months since you had...

Europe's second wave is worse than the first. What went so wrong, and what can it learn from countries like Vietnam?

Oct 15, 2020 14:25 pm UTC| Health

Europe is again in the grip of a COVID-19 resurgence, with outbreak hot-spots in the United Kingdom, Spain and France each reporting thousands of new daily cases. The level of infections are now higher than in March and...

A COVID-19 vaccine may come without a needle, the latest vaccine to protect without jabbing

Oct 01, 2020 15:28 pm UTC| Health

Vaccines are traditionally administered with a needle, but this isnt the only way. For example, certain vaccines can be delivered orally, as a drop on the tongue, or via a jet-like device. Vaccines that appear...

Dry, wet, barking, hacking: a guide to coughs in the time of coronavirus

Apr 18, 2020 06:41 am UTC| Health

For centuries, doctors and care givers have listened to the different types of cough in search of clues to help diagnose underlying disease. Coughs are a valuable diagnostic tool, but how do you know if youve got a...

1 

Economy

EU Delays Mercosur Free Trade Agreement Signing Amid Ukraine War Funding Talks

The European Union has decided to delay the formal signing of its long-anticipated free trade agreement with the Mercosur bloc, as EU leaders convened in Brussels to prioritize discussions on funding Ukraines war effort....

Precious Metals Rally as Silver and Platinum Outperform on Rate Cut Bets

Gold prices edged slightly lower in Asian trading on Friday but were still on track to post modest weekly gains, as strong safe-haven demand continued to support the precious metals market. At the same time, silver and...

Oil Prices Steady in Asia but Headed for Weekly Loss on Supply Glut Concerns

Oil prices were mostly steady during Asian trading on Friday, but both major benchmarks were still on track to record a second consecutive weekly decline as persistent concerns over a global supply glut continued to...

New Zealand Business Confidence Hits 30-Year High as Economic Outlook Improves

New Zealands business confidence surged sharply in December, reaching its highest level in three decades, according to the latest ANZ Bank Business Outlook survey released on Friday. The data highlights growing optimism...

BOJ Poised for Historic Rate Hike as Japan Signals Shift Toward Monetary Normalization

The Bank of Japan (BOJ) is widely expected to raise interest rates to a three-decade high, marking another milestone in its gradual exit from ultra-loose monetary policy. At the conclusion of its two-day meeting on Friday,...

Politics

U.S. and China Push for Ceasefire as Thailand–Cambodia Border Clashes Escalate

China and the United States are intensifying separate diplomatic efforts to revive a ceasefire between Thailand and Cambodia, as Southeast Asian leaders prepare for a crucial ASEAN meeting aimed at addressing the worst...

Syria, Kurds and U.S. Race to Show Progress on SDF Integration Deal

Syrian, Kurdish and U.S. officials are intensifying diplomatic efforts ahead of a year-end deadline to demonstrate progress on a long-stalled agreement to integrate Kurdish-led forces into the Syrian state, according to...

Putin Signals Possible Peace or Continued War in Ukraine at Major Year-End Address

Russian President Vladimir Putin is expected to send a significant signal to the United States and European powers regarding the future of the Ukraine war when he speaks at his annual end-of-year news conference on Friday....

Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy

The U.S. government under President Donald Trump has launched a formal review that could pave the way for the first-ever shipments of Nvidias H200 artificial intelligence chips to China, according to multiple sources...

Trump Signs Order to Ease Federal Marijuana Rules, Signaling Major Policy Shift

U.S. President Donald Trump has signed an executive order directing federal agencies to loosen regulations on marijuana, a move that could mark one of the most significant changes in U.S. cannabis policy in decades. The...

Science

Jared Isaacman Confirmed as NASA Administrator, Becomes 15th Leader of U.S. Space Agency

The U.S. Senate has officially confirmed billionaire private astronaut Jared Isaacman as the new NASA administrator, making him the 15th leader in the agencys history. The confirmation, which took place on Wednesday, marks...

Senate Sets December 8 Vote on Trump’s NASA Nominee Jared Isaacman

The U.S. Senate Commerce Committee announced it will vote on December 8 on President Donald Trumps renewed nomination of private astronaut and tech entrepreneur Jared Isaacman to lead NASA. Isaacman, known for his...

NASA Cuts Boeing Starliner Missions as SpaceX Pulls Ahead

NASA has significantly scaled back Boeings Starliner program after years of technical issues and delays, announcing that the next Starliner mission to the International Space Station (ISS) will fly without astronauts. The...

Blue Origin’s New Glenn Achieves Breakthrough Success With First NASA Mission

Blue Origins massive New Glenn rocket marked a major milestone as it completed its first mission for paying customers, sending two NASA satellites toward Mars and successfully landing its reusable booster at sea. The...

Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment

Cogent Biosciences (NASDAQ: COGT) shares skyrocketed over 120% after the biotech company announced groundbreaking results from its Phase 3 PEAK trial evaluating bezuclastinib in combination with sunitinib for patients with...

Technology

TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement

TikTok has taken a major step toward securing its future in the United States after its Chinese parent company, ByteDance, announced it has signed binding agreements with three major investors to form a new joint venture...

Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz

Oracle Corporation (NYSE: ORCL) shares surged sharply in extended trading on Thursday, reflecting renewed investor optimism fueled by reports of a potential U.S. TikTok transaction and fresh fundraising discussions...

Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law

Apple has announced a major shift in its App Store policies in Japan, opening iPhones and other Apple devices to alternative app stores in order to comply with new competition laws aimed at reshaping the countrys...

Micron Technology Forecasts Surge in Revenue and Earnings on AI-Driven Memory Demand

Micron Technology delivered record first-quarter results and issued a bullish forecast for the current quarter, driven by rising memory prices and strong demand linked to artificial intelligence workloads. The upbeat...

Oracle Stock Slides After Blue Owl Exit Report, Company Says Michigan Data Center Talks Remain on Track

Oracle shares fell more than 4% on Wednesday after a Financial Times report claimed that Blue Owl Capital, Oracles largest U.S. data center partner, decided not to support a planned $10 billion data center project in...
  • Market Data
Close

Welcome to EconoTimes

Sign up for daily updates for the most important
stories unfolding in the global economy.